Lithium hypercalcemia, hyperparathyroidism, and cinacalcet [8]

Kidney International

Volumn 71, Issue 5, 2007, Pages 470-

  Gregoor, P Smak ^a   De Jong, G M T ^a  

^a A Schweitzer Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CINACALCET; LITHIUM;

CASE REPORT; DEPRESSION; DRUG DOSE TITRATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; LABORATORY TEST; LETTER; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 33847235688     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002065     Document Type: Letter

References (5)

1. Cunningham J, Danese M, Olson K et al. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005; 68: 1793.
2. Nemeth EF, Bennett SA. Tricking the parathyroid gland with novel calcimimetic agents (editorial). Nephrol Dial Transplant 1998; 13: 1923.
3. Garfinkel PE, Ezrin C, Stancer HC. Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 1973; ii: 331-332.
4. Brown EM. Lithium induces abnormal calcium regulated PTH release in dispersed bovine parathyroid cells. J Clin Endocrinol Metab 1981; 52: 1046-1048.
5. Mallette LE, Khouri K, Zengotita H et al. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab 1989; 68: 654-660.